Neuberger Berman Group LLC increased its stake in shares of STERIS PLC (NYSE:STE) by 7.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,197 shares of the medical equipment provider’s stock after purchasing an additional 562 shares during the quarter. Neuberger Berman Group LLC’s holdings in STERIS PLC were worth $668,000 as of its most recent filing with the SEC.
Several other hedge funds also recently bought and sold shares of STE. BlackRock Inc. boosted its holdings in shares of STERIS PLC by 16,597.1% during the first quarter. BlackRock Inc. now owns 5,272,105 shares of the medical equipment provider’s stock worth $366,200,000 after purchasing an additional 5,240,530 shares during the period. Wellington Management Group LLP boosted its holdings in shares of STERIS PLC by 77.8% during the first quarter. Wellington Management Group LLP now owns 6,529,610 shares of the medical equipment provider’s stock worth $453,547,000 after purchasing an additional 2,856,744 shares during the period. Bessemer Group Inc. boosted its holdings in shares of STERIS PLC by 944,971.1% during the second quarter. Bessemer Group Inc. now owns 1,342,001 shares of the medical equipment provider’s stock worth $109,373,000 after purchasing an additional 1,341,859 shares during the period. Harbour Capital Advisors LLC acquired a new stake in shares of STERIS PLC during the second quarter worth approximately $3,750,000. Finally, Prudential Financial Inc. boosted its holdings in shares of STERIS PLC by 470.7% during the first quarter. Prudential Financial Inc. now owns 344,755 shares of the medical equipment provider’s stock worth $23,947,000 after purchasing an additional 284,350 shares during the period. Institutional investors and hedge funds own 93.33% of the company’s stock.
Several analysts recently commented on STE shares. Wellington Shields cut shares of STERIS PLC from a “gradually accumulate” rating to a “hold” rating in a report on Monday, June 5th. Zacks Investment Research upgraded shares of STERIS PLC from a “sell” rating to a “hold” rating in a research note on Friday, June 23rd. BidaskClub cut shares of STERIS PLC from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Finally, Raymond James Financial, Inc. lifted their target price on shares of STERIS PLC from $90.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, August 9th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $86.75.
In other STERIS PLC news, VP Karen L. Burton sold 3,270 shares of the company’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $85.70, for a total transaction of $280,239.00. Following the completion of the transaction, the vice president now owns 11,807 shares of the company’s stock, valued at approximately $1,011,859.90. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Richard Martin Steeves sold 156,072 shares of the company’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $87.13, for a total value of $13,598,553.36. Following the transaction, the director now directly owns 9,362 shares of the company’s stock, valued at approximately $815,711.06. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 176,086 shares of company stock valued at $15,297,621. Insiders own 2.55% of the company’s stock.
Shares of STERIS PLC (NYSE STE) opened at 87.08 on Thursday. STERIS PLC has a 1-year low of $63.80 and a 1-year high of $88.11. The firm has a market capitalization of $7.42 billion, a PE ratio of 62.29 and a beta of 1.29. The firm has a 50-day moving average of $85.66 and a 200-day moving average of $78.30.
STERIS PLC (NYSE:STE) last released its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. STERIS PLC had a return on equity of 11.39% and a net margin of 4.63%. The firm had revenue of $608.00 million during the quarter, compared to the consensus estimate of $597.66 million. During the same quarter in the prior year, the firm posted $0.79 EPS. The business’s revenue was down 4.8% on a year-over-year basis. On average, equities research analysts anticipate that STERIS PLC will post $4.06 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th will be given a dividend of $0.31 per share. The ex-dividend date of this dividend is Friday, August 25th. This represents a $1.24 dividend on an annualized basis and a yield of 1.42%. This is an increase from STERIS PLC’s previous quarterly dividend of $0.28. STERIS PLC’s dividend payout ratio is 88.57%.
About STERIS PLC
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related companies with MarketBeat.com's FREE daily email newsletter.